The utility of marginal donors in liver transplantation

The shortage of organs has led centers to expand their criteria for the acceptance of marginal donors. The combination of multiple marginal factors seems to be additive on graft injury. In this review, the utility of various marginal donors in patients requiring liver transplantation will be described, including older donors, steatotic livers, non‐heart‐beating donors, donors with viral hepatitis, and donors with malignancies. The pathophysiology of the marginal donor will be discussed, along with strategies for minimizing the ischemia reperfusion injury experienced by these organs. Finally, new strategies for improving the function of the marginal/expanded donor liver will be reviewed. (Liver Transpl 2003;9:651‐663.)

[1]  N. L. Johnson,et al.  Multivariate Analysis , 1958, Nature.

[2]  G. Schmid-Schönbein,et al.  Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. , 1983, The American journal of pathology.

[3]  H. Popper.  Aging and the liver. , 1986, Progress in liver diseases.

[4]  B. Brüne,et al.  Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. , 1987, Molecular pharmacology.

[5]  B. Markus,et al.  HLA histocompatibility and liver transplant survival. , 1987, Transplantation proceedings.

[6]  P. Grambsch,et al.  INFLUENCE OF POSITIVE LYMPHOCYTE CROSSMATCH AND HLA MISMATCHING ON VANISHING BILE DUCT SYNDROME IN HUMAN LIVER ALLOGRAFTS , 1988, Transplantation.

[7]  T E Starzl,et al.  Primary nonfunction of hepatic allografts with preexisting fatty infiltration. , 1989, Transplantation.

[8]  D. Grant,et al.  Analysis of donor and recipient variables and early graft function after orthotopic liver transplantation. , 1989, Transplantation proceedings.

[9]  I. Ginsburg,et al.  Endothelial cell killing by neutrophils. Synergistic interaction of oxygen products and proteases. , 1989, The American journal of pathology.

[10]  D. Grant,et al.  The use of older donor livers for hepatic transplantation. , 1990, Transplantation.

[11]  M. Morino,et al.  The outcome of steatotic grafts in liver transplantation. , 1991, Transplantation proceedings.

[12]  R. Furchgott,et al.  Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. , 1991, Blood vessels.

[13]  J. Alexander,et al.  The use of "marginal" donors for organ transplantation. The influence of donor age on outcome. , 1991, Transplantation.

[14]  S. Knechtle,et al.  The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. , 1991, Transplantation.

[15]  T. Starzl,et al.  A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies , 1992, Hepatology.

[16]  P. Clavien,et al.  Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. , 1992, Transplantation.

[17]  G. Klintmalm,et al.  THE USE OF mARGINAL DONORS FOR LIVER TRANSPLANTATION A RETROSPECTIVE STUDY OF 365 LIVER DONORS 1,2 , 1992, Transplantation.

[18]  I. Tsukamoto,et al.  Effect of ageing on rat liver regeneration after partial hepatectomy. , 1993, Biochemistry and molecular biology international.

[19]  M. Stegall,et al.  Risk factors for primary dysfunction after liver transplantation--a multivariate analysis. , 1993, Transplantation.

[20]  S. Knechtle,et al.  Histocompatibility and liver transplantation. , 1993, Surgery.

[21]  H. Bismuth,et al.  Liver transplantation from elderly donors. , 1993, Transplantation proceedings.

[22]  J. Sanabria,et al.  Role of platelets in hepatic allograft preservation injury in the rat , 1993, Hepatology.

[23]  M. Vaubourdolle,et al.  Preservation-induced liver injury. Clinical aspects, mechanisms and therapeutic approaches. , 1993, Journal of hepatology.

[24]  S. Silbiger,et al.  THE IMPACT OF GENDER ON RENAL TRANSPLANTATION , 1994, Transplantation.

[25]  G Opelz,et al.  The influence of HLA compatibility on graft survival after heart transplantation. The Collaborative Transplant Study. , 1994, The New England journal of medicine.

[26]  P. Mcmaster,et al.  Policies in Europe on "marginal quality" donor livers , 1994, The Lancet.

[27]  M. Levy,et al.  HLA COMPATIBILITY AND LIVER TRANSPLANT OUTCOME Improved Patient Survival by HLA and Cross‐Matching , 1994, Transplantation.

[28]  H. Bismuth,et al.  Deleterious effect of extended cold ischemia time on the posttransplant outcome of aged livers. , 1995, Transplantation proceedings.

[29]  G. Klintmalm,et al.  IMPACT OF PRETRANSPLANT RENAL FUNCTION ON SURVIVAL AFTER LIVER TRANSPLANTATION , 1995, Transplantation.

[30]  J. Tredger,et al.  Contribution of true cold and rewarming ischemia times to factors determining outcome after orthotopic liver transplantation. , 1995, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[31]  R. Busuttil,et al.  CORRELATION BETWEEN DONOR AGE AND THE PATTERN OF LIVER GRAFT RECOVERY AFTER TRANSPLANTATION , 1995, Transplantation.

[32]  J. Emond,et al.  The Risk Of Transmission Of Hepatitis B From Hbsag(-), Hbcab(+), Hbigm(-) Organ Donors , 1995, Transplantation.

[33]  G. Klintmalm,et al.  HLA compatibility and liver transplant outcome: improved patient survival by HLA and crossmatching. , 1995, Transplantation proceedings.

[34]  J. Lemasters,et al.  Glycine in Carolina rinse solution reduces reperfusion injury, improves graft function, and increases graft survival after rat liver transplantation. , 1995, Transplantation proceedings.

[35]  J. Lemasters,et al.  Dual role of Kupffer cell activation and endothelial cell damage in reperfusion injury to livers stored for transplantation surgery , 1995, Journal of gastroenterology and hepatology.

[36]  T. Starzl,et al.  Experience with liver and kidney allografts from non-heart-beating donors. , 1995, Transplantation.

[37]  M. Miyazaki,et al.  Reduction of hepatic acute phase response after partial hepatectomy in elderly patients , 1996, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

[38]  C. Sansalone,et al.  Is the use of marginal donors justified in liver transplantation? Analysis of results and proposal of modern criteria. , 1996 .

[39]  R. Fisher,et al.  The impact of a positive crossmatch upon outcome after liver transplantation. , 1996, Transplantation.

[40]  K. Batts,et al.  Use of fatty donor liver is associated with diminished early patient and graft survival. , 1996, Transplantation.

[41]  M. Castagneto,et al.  Marginal donors for patients on regular waiting lists for liver transplantation , 1996, Transplant international : official journal of the European Society for Organ Transplantation.

[42]  Y. Takei,et al.  Protection by Carolina rinse solution, acidotic pH, and glycine against lethal reperfusion injury to sinusoidal endothelial cells of rat livers stored for transplantation. , 1996, Transplantation.

[43]  H. Shinohara,et al.  Superiority of HTK solution to UW solution for tissue oxygenation in living related liver transplantation. , 1996, Transplantation proceedings.

[44]  C. Sansalone,et al.  Is the use of marginal donors justified in liver transplantation? Analysis of results and proposal of modern criteria , 1996, Transplant international : official journal of the European Society for Organ Transplantation.

[45]  K. Olthoff,et al.  A prospective study on the reliability and cost effectiveness of preoperative ultrasound screening of the "marginal" liver donor. , 1996, Transplantation.

[46]  Donor age and outcome of liver transplantation , 1996 .

[47]  J. Lake,et al.  Outcome of patients with renal insufficiency undergoing liver or liver-kidney transplantation. , 1996, Transplantation.

[48]  R. Wiesner,et al.  Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. , 1997, Gastroenterology.

[49]  G. Fonarow,et al.  The alternate recipient list for heart transplantation: does it work? , 1997, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[50]  S. Nasraway,et al.  Pretransplant renal dysfunction predicts poorer outcome in liver transplantation. , 1997, Clinical nephrology.

[51]  J. D. Waters,et al.  Expanded liver donor age over 60 years for hepatic transplantation. , 1997, Transplantation proceedings.

[52]  R. Wiesner,et al.  The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient. , 1997, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[53]  W. Bechstein,et al.  Pilot study: Carolina Rinse Solution improves graft function after orthotopic liver transplantation in humans. , 1997, Transplantation proceedings.

[54]  J. Tredger,et al.  Treatment of experimental ischemia/reperfusion injury with S-adenyosylmethionine: evidence that donor pretreatment complements other regimens. , 1997, Transplantation.

[55]  T. Fishbein,et al.  Use of livers with microvesicular fat safely expands the donor pool. , 1997, Transplantation.

[56]  N. Ohkohchi,et al.  Why is fatty liver unsuitable for transplantation? Deterioration of mitochondrial ATP synthesis and sinusoidal structure during cold preservation of a liver with steatosis. , 1997, Transplantation proceedings.

[57]  M. L. de la Mata,et al.  Impact of marginal quality donors on the outcome of liver transplantation. , 1997, Transplantation proceedings.

[58]  R. Bentley,et al.  Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation , 1998, Hepatology.

[59]  L. Grande,et al.  Expanded liver donor age over 60 years for hepatic transplantation. , 1998, Clinical transplants.

[60]  M. Bronner,et al.  Donor-recipient sharing of HLA class II alleles predicts earlier recurrence and accelerated progression of hepatitis C following liver transplantation. , 1998, Tissue antigens.

[61]  G. Klintmalm,et al.  Long-term outcome of patients transplanted with livers from hepatitis C-positive donors. , 1998, Transplantation.

[62]  I. Bilbao,et al.  Risk factors for acute renal failure requiring dialysis after liver transplantation. , 1998, Clinical transplantation.

[63]  P. Clavien.  Sinusoidal endothelial cell injury during hepatic preservation and reperfusion , 1998, Hepatology.

[64]  M A Ureña,et al.  Assessing risk of the use of livers with macro and microsteatosis in a liver transplant program. , 1998, Transplantation proceedings.

[65]  A. Minguela,et al.  Effect of partial HLA class I match on acute rejection in viral pre-infected human liver allograft recipients. , 1998, Transplantation.

[66]  J. Visa,et al.  S-adenosyl L-methionine effect on hepatic allografts procured from non-heart-beating donor pigs. , 1999, Transplantation proceedings.

[67]  Randall G. Lee,et al.  Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. , 1999, Gastroenterology.

[68]  J Zaky,et al.  Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. , 1999, The Journal of clinical investigation.

[69]  J. Fung,et al.  Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors. , 1999, Transplantation.

[70]  G. Zibari,et al.  P-selectin contributes to the initial recruitment of rolling and adherent leukocytes in hepatic venules after ischemia/reperfusion. , 1999, Shock.

[71]  U. Neumann,et al.  Is the use of marginal liver grafts justified? , 1999, Transplantation proceedings.

[72]  I. García,et al.  Use of octogenarian livers safely expands the donor pool. , 1999 .

[73]  M. Sterneck,et al.  Liver transplantation for acute liver failure. , 1999, European journal of gastroenterology & hepatology.

[74]  S. Arii,et al.  Morphologic alteration of hepatocytes and sinusoidal endothelial cells in rat fatty liver during cold preservation and the protective effect of hepatocyte growth factor. , 1999, Transplantation.

[75]  R. Wiesner,et al.  Recurrent and new hepatitis C virus infection after liver transplantation , 1999, Hepatology.

[76]  A. Choi,et al.  Carbon Monoxide Generated by Heme Oxygenase 1 Suppresses Endothelial Cell Apoptosis , 2000, The Journal of experimental medicine.

[77]  J. Briceño,et al.  A proposal for scoring marginal liver grafts , 2000, Transplant international : official journal of the European Society for Organ Transplantation.

[78]  R. Sawyer,et al.  Increased late hepatic artery thrombosis rate and decreased graft survival after liver transplants with zero cross‐reactive group mismatches , 2000, Liver transplantation.

[79]  L. Toledo-Pereyra,et al.  L-Selectin and chemokine response after liver ischemia and reperfusion. , 2000, The Journal of surgical research.

[80]  L. Toledo-Pereyra,et al.  P-selectin and chemokine response after liver ischemia and reperfusion. , 2000, Journal of the American College of Surgeons.

[81]  A. Çoker,et al.  Beneficial effects of pentoxifylline pretreatment in non-heart-beating donors in rats. , 2000, Transplantation.

[82]  R. Hasz,et al.  CONTROLLED NON-HEART-BEATING DONOR LIVER TRANSPLANTATION: A Successful Single Center Experience, with Topic Update , 2000, Transplantation.

[83]  A. Choi,et al.  Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway , 2000, Nature Medicine.

[84]  M. Manyalich,et al.  l-ARGININE REDUCES LIVER AND BILIARY TRACT DAMAGE AFTER LIVER TRANSPLANTATION FROM NON-HEART-BEATING DONOR PIGS1 , 2000, Transplantation.

[85]  H. Sanfey,et al.  Implication of advanced donor age on the outcome of liver transplantation , 2000, Clinical transplantation.

[86]  S. Strasberg,et al.  Glutathione, lactobionate, and histidine: cryptic inhibitors of matrix metalloproteinases contained in university of wisconsin and histidine/tryptophan/ketoglutarate liver preservation solutions , 2000, Hepatology.

[87]  A. Sheil,et al.  Donor fatty (steatotic) liver allografts in orthotopic liver transplantation: a revisit. , 2000, Transplantation proceedings.

[88]  M. Charlton.  Hepatitis C Infection in Liver Transplantation , 2001, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[89]  L. Horwitz,et al.  A NOVEL IRON CHELATOR IN COMBINATION WITH A P-SELECTIN ANTAGONIST PREVENTS ISCHEMIA/REPERFUSION INJURY IN A RAT LIVER MODEL1 , 2001, Transplantation.

[90]  J. Córdoba,et al.  De novo hepatitis B after liver transplantation from hepatitis B core antibody—Positive donors in an area with high prevalence of anti‐HBc positivity in the donor population , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[91]  S. Wilhelm,et al.  THE USE OF THE ENDOTHELIN RECEPTOR ANTAGONIST, TEZOSENTAN, BEFORE OR AFTER RENAL ISCHEMIA PROTECTS RENAL FUNCTION1 , 2001, Transplantation.

[92]  J. Gornbein,et al.  Preoperative factors associated with outcome and their impact on resource use in 1148 consecutive primary liver transplants. , 2001, Transplantation.

[93]  G. Molema,et al.  DONOR BRAIN DEATH REDUCES SURVIVAL AFTER TRANSPLANTATION IN RAT LIVERS PRESERVED FOR 20 HR1 , 2001, Transplantation.

[94]  E. Collisson,et al.  A 10-Year Experience of Liver Transplantation for Hepatitis C: Analysis of Factors Determining Outcome in Over 500 Patients , 2001, Annals of surgery.

[95]  C. Cancrini,et al.  Liver transplantation: expanding the donor pool. , 2001, Transplantation proceedings.

[96]  M. Kukan,et al.  Improvement of rat liver function by energy repletion after the preservation period: implications for hepatic graft management. , 2001, Cryobiology.

[97]  J. Figueras,et al.  The impact of donor age on liver transplantation: influence of donor age on early liver function and on subsequent patient and graft survival. , 2001, Transplantation.

[98]  H. Schrem,et al.  Liver Transplantation After Organ Preservation With Normothermic Extracorporeal Perfusion , 2001, Annals of surgery.

[99]  A. Lu,et al.  Transplantation of hepatitis C–positive livers in hepatitis C–positive patients is equivalent to transplanting hepatitis C–negative livers , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[100]  N. Habib,et al.  Hepatic ischemia-reperfusion injury. , 2001, American journal of surgery.

[101]  B. Ke,et al.  Heme Oxygenase‐1 Overexpression Protects Rat Livers from Ischemia/Reperfusion Injury with Extended Cold Preservation , 2001, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[102]  T. V. van Gulik,et al.  Evaluation of rat liver apoptotic and necrotic cell death after cold storage using UW, HTK, and celsior , 2002, Transplantation.

[103]  F. Delmonico,et al.  Transplant tumor registry: donors with central nervous system tumors1. , 2002, Transplantation.

[104]  P. Thuluvath,et al.  Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation , 2002, Hepatology.

[105]  W. Marks,et al.  Transplant tumor registry: donor related malignancies , 2002, Transplantation.

[106]  J. Briceño,et al.  Influence of marginal donors on liver preservation injury , 2002, Transplantation.

[107]  H. Volk,et al.  Heme oxygenase-1 gene transfer inhibits inducible nitric oxide synthase expression and protects genetically fat Zucker rat livers from ischemia-reperfusion injury. , 2002, Transplantation.

[108]  H. Volk,et al.  P‐Selectin Glycoprotein Ligand‐1 (rPSGL‐Ig)‐Mediated Blockade of CD62 Selectin Molecules Protects Rat Steatotic Liver Grafts from Ischemia/Reperfusion Injury , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[109]  S. Dry,et al.  Improved survival through the reduction of ischemia-reperfusion injury after rat intestinal transplantation using selective P-selectin blockade with P-selectin glycoprotein ligand-Ig. , 2002, Transplantation proceedings.

[110]  A. Demetris,et al.  Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis1 , 2002, Transplantation.

[111]  H. Volk,et al.  Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1 , 2002, Transplantation.

[112]  K. Olthoff,et al.  The outcome of liver grafts procured from hepatitis C-positive donors. , 2002, Transplantation.

[113]  Jorge Ortiz,et al.  Safe use of livers from donors with positive hepatitis B core antibody , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[114]  P. Thuluvath,et al.  Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States , 2002, Hepatology.

[115]  L. Johnson,et al.  Role of gender and race mismatch and graft failure in patients undergoing liver transplantation , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[116]  R. Busuttil,et al.  Heme oxygenase-1 system in organ transplantation. , 2002, Transplantation.

[117]  G. Tisone,et al.  Marginal donors in liver transplantation. , 2004, Transplantation proceedings.